Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,144 public trials 2,036 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

NCT04595162

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Not specified

View Trial Details

Not yet recruiting

Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas

NCT04520529

Conditions: Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Detection and Pathogenesis of Novel Protein F

NCT04338386

Conditions: Blood Protein Disorders, Cardiac Disease, Cardiovascular Diseases, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

NCT02497898

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Enrolling by invitation

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

NCT06788509

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +30 more
Locations: Linear Clinical Research Ltd Nedlands, Australia

Scientia Clinical Research Randwick, Australia

Ghent University Hospital Ghent, Belgium

Hopital Claude Huriez Lille, France

View all 39 locations

View Trial Details

Enrolling by invitation

Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM

NCT07775313

Conditions: Agammaglobulinemia, Blood Protein Disorders, DNA Virus Infections, +19 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by invitation

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

NCT03226704

Conditions: Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Hematologic Diseases, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by invitation

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

NCT03628612

Conditions: ALL, Adult and Pediatric, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: University of Miami Miami, Florida, United States

Washington University in St. Louis St Louis, Missouri, United States

St David's South Austin Medical Center Austin, Texas, United States

Queen Elizabeth University Hospital Glasgow, United Kingdom

View Trial Details

Enrolling by invitation

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

NCT07168486

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
Locations: University of Maryland, Baltimore Baltimore, Maryland, United States

View Trial Details

Enrolling by invitation

Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis

NCT07103863

Conditions: AL Amyloidosis (AL), Amyloid Neuropathies, Amyloid Neuropathies, Familial, +22 more
Locations: Beijing Anzhen Hospital Beijing, Beijing Municipality, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions